Skip to content
MedsAcross

Molecule

Technetium tc-99m sodium pertechnetate

Available on request
Presentations
14
Brands
2
Manufacturers
2
Available from stock
0

Technetium tc-99m sodium pertechnetate is a radioactive diagnostic agent. It is available as injection for intravenous use. MedsAcross supplies Technetium tc-99m sodium pertechnetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
18 July 1974
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravenous
Dosage forms
Injection
Identifiers
UNII A0730CX801RxCUI 10349CAS 23288-60-0Q27273460

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

The Technelite generator is a source of sodium pertechnetate Tc 99m for use in the preparation of FDA-approved diagnostic radiopharmaceuticals, as described in the labeling of these diagnostic radiopharmaceutical kits. Sodium Pertechnetate Tc 99m Injection is used IN ADULTS as an agent for: Thyroid Imaging Salivary Gland Imaging Urinary Bladder Imaging (direct isotopic cystography) for the detection of vesico-ureteral reflux. Nasolacrimal Drainage System Imaging Sodium Pertechnetate Tc 99m Injection is used IN CHILDREN as an agent for: Thyroid Imaging Urinary Bladder Imaging (direct isotopic cystography) for the detection of vesico-ureteral reflux.

Source: US FDA prescribing information

Dosing overview

Sodium Pertechnetate Tc 99m Injection is usually administered by intravascular injection. For imaging the urinary bladder and ureters (direct isotopic cystography), the Sodium Pertechnetate Tc 99m Injection is administered by direct instillation aseptically into the bladder via a urethral catheter, following which the catheter is flushed with approximately 200 mL of 0.9% Sodium Chloride Injection, USP directly into the bladder. The dosage employed varies with each diagnostic procedure. When imaging the nasolacrimal drainage system, instill the Sodium Pertechnetate Tc 99m Injection by the use of a device such as a micropipette or similar method which will ensure the accuracy of the dose.

Source: US FDA prescribing information

Warnings and precautions

Radiation risks associated with the use of Sodium Pertechnetate Tc 99m Injection are greater in children than in adults and, in general, the younger the child, the greater the risk owing to greater absorbed radiation doses and longer life-expectancy. These greater risks should be taken firmly into account in all benefit-risk assessments involving children. Long-term cumulative radiation exposure may be associated with an increased risk of cancer.

Source: US FDA prescribing information

Side effects

Allergic reactions including anaphylaxis have been reported infrequently following the administration of Sodium Pertechnetate Tc 99m Injection.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

14 presentations of Technetium tc-99m sodium pertechnetate, sorted by availability.

MedicineManufacturerRegisterAvailability
TechneLite 250 mCi/mL injectionIntravenousShine SpectUS FDAAvailable on request
Ultra-Technekow V4 1 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 1.5 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 11 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 14 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 16 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 19 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 2 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 2.5 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 3 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 3.5 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 5 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 6 Ci injectionIntravenousCuriumUS FDAAvailable on request
Ultra-Technekow V4 7.5 Ci injectionIntravenousCuriumUS FDAAvailable on request

Brands by market

2 brand names across 1 markets.

Brand names by country

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 18 July 1974Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Technetium tc-99m sodium pertechnetate available for export from India?

Yes, on request. MedsAcross lists 14 presentations of Technetium tc-99m sodium pertechnetate and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Technetium tc-99m sodium pertechnetate have?

The catalogue lists 2 brand names for Technetium tc-99m sodium pertechnetate, including TechneLite, Ultra-Technekow V4.

Is Technetium tc-99m sodium pertechnetate approved by the US FDA?

Yes. The US FDA first approved Technetium tc-99m sodium pertechnetate on 18 July 1974, according to Drugs@FDA.

Does Technetium tc-99m sodium pertechnetate need cold chain shipping?

No listed presentation of Technetium tc-99m sodium pertechnetate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. TechneLite prescribing information (Shine Spect). U.S. National Library of Medicine, DailyMed. Retrieved 2 September 2026

Request Technetium tc-99m sodium pertechnetate for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.